North America:
The North America autoimmune disease treatment market is advanced and rapidly evolving, supported by a robust healthcare infrastructure and significant investments in research and development. The United States leads the market with its focus on innovative treatment approaches and extensive clinical trials. The prevalence of autoimmune diseases and a high level of healthcare...